BioCatalystWatch
GPCRWorkspace / GPCR / OverviewCompany library
Structure Therapeutics Inc. logo

Structure Therapeutics Inc.

Structure Therapeutics Inc. (GPCR)

Website

Price
Market cap
Next catalystExpected Q4 2026Aleniglipron (GSBR-1290) · Trial initiationCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

Small molecule

GLP-1 receptor (GLP-1R)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Small molecule

GLP-1 receptor (GLP-1R)

PreINDP1P2P3FilingApproved
Upcoming / outlook

ACCG-2671

Small molecule

Amylin receptor × Calcitonin receptor (CTR)

PreINDP1P2P3FilingApproved
Upcoming / outlook

ACCG-3535

Small molecule

Amylin receptor × Calcitonin receptor (CTR)

PreINDP2P3FilingApproved
Upcoming / outlook

ACCG-2671 + aleniglipron combination

GLP-1 receptor (GLP-1R) × Amylin receptor

Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Small molecule

GLP-1 receptor (GLP-1R)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Small molecule

GLP-1 receptor (GLP-1R)

PreINDP1P2P3FilingApproved
Upcoming / outlook

ACCG-3535

Small molecule

Amylin receptor × Calcitonin receptor (CTR)

PreINDP2P3FilingApproved
Upcoming / outlook

ACCG-2671 + aleniglipron combination

GLP-1 receptor (GLP-1R) × Amylin receptor

Upcoming / outlook

  • Timing and evidence

ACCG-2671

Small molecule

Amylin receptor × Calcitonin receptor (CTR)

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

Aleniglipron (GSBR-1290)

Small molecule

GLP-1 receptor (GLP-1R)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Small molecule

LPA1 receptor (LPA1R)

PreINDP1P2P3FilingApproved

History / paused

ACCG-2671

Small molecule

Amylin receptor × Calcitonin receptor (CTR)

PreINDP1P2P3FilingApproved

Small molecule

Apelin receptor (APJ/APJR)

PreINDP1P2P3FilingApproved

Small molecule

Apelin receptor (APJ/APJR)

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

GPCR PR & News

PR & News

GPCR SEC archive